Key Record Dates
ClinicalTrials.gov Identifier: | NCT05461664 |
---|---|
Brief Title: | Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA |
First Submitted : | July 9, 2022 |
First Submitted that Met QC Criteria : | July 15, 2022 |
First Posted : | July 18, 2022 |
Last Update Submitted that Met QC Criteria : | July 15, 2022 |
Last Update Posted : | July 18, 2022 |